Results from a recently published randomized, double-blind, placebo-controlled clinical trial show that supplementation with ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Concept Medical Inc. is proud to announce the successful enrollment of the first patients in the STARS DAPT randomized controlled trial.

Telesurgery (operating on a patient remotely using a surgical robot via a secure telecommunication link) appears to be as ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

ScreenPoint Medical, The Breast AI Company, highlights new research from Sweden's Mammography Screening with Artificial Intelligence (MASAI) large-scale randomized controlled trial, which shows that ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the completion of enrollment in ACES-EMB, the first randomized-controlled trial evaluating whether ...

Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that Ascletis ...

This clinical trial is designed to demonstrate that TETRANITE® can immediately fixate cranial flaps and enable bone fusion in craniotomy and cranioplasty procedures to improve cosmesis, increase flap ...

“The topline results from Ascletis’ Phase 3 open-label acne trial in China build additional confidence in the clinical potential of FASN inhibition in acne,” said David Happel, Chief Executive Officer ...

Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease, having met the primary ...

CHOICE-2 supports intra-arterial alteplase after successful reperfusion ...